Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

North Korean hackers tried to steal Pfizer vaccine know-how, lawmaker says

Published 02/16/2021, 03:25 AM
Updated 02/16/2021, 05:45 AM
© Reuters. FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and a syringe are seen in front of the Pfizer logo in this illustration

By Sangmi Cha and Hyonhee Shin

SEOUL (Reuters) - South Korea's intelligence agency has said North Korea attempted to steal information on coronavirus vaccines and treatments by hacking Pfizer Inc (NYSE:PFE), a lawmaker briefed by the agency said on Tuesday.

Digital espionage targeting health bodies, vaccine scientists and drugmakers has surged during the COVID-19 pandemic as state-backed hacking groups scramble to secure the latest research and information about the outbreak.

Ha Tae-keung, an opposition member of the parliamentary intelligence panel, said the pharmaceutical giant was among those hacked in the bid to steal information on vaccines and treatments.

"There were attempts to steal COVID vaccine and treatment technology during cyber attacks and Pfizer was hacked," he said.

Speaking to reporters after a briefing by the agency, Ha did not elaborate on the timing or success of the attempt, a transcript of his remarks reviewed by Reuters showed.

Ha's office confirmed his comments but gave no details.

Pfizer's offices in Asia and South Korea did not have an immediate comment.

Tuesday's news comes after attempts last year by suspected North Korean hackers to break into the systems of at least nine healthcare firms, such as Johnson & Johnson (NYSE:JNJ), Novavax (NASDAQ:NVAX) Inc, and AstraZeneca (NASDAQ:AZN).

South Korea's National Intelligence Service (NIS) has said it had foiled attempts by its neighbour to hack into South Korean firms developing coronavirus vaccines.

North Korea is often accused of turning to an army of hackers to fill its cash-strapped coffers amid international sanctions that ban most international trade with it.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Health experts have said the North's hackers may be more interested in selling the stolen data than using it to develop a homegrown vaccine.

North Korea is expected to receive nearly 2 million doses of the AstraZeneca-Oxford COVID-19 vaccine by the first half of this year through the COVAX vaccine-sharing programme.

It has not confirmed any infections, but the NIS had said an outbreak could not be ruled out as the North had trade and people-to-people exchanges with China before closing the border in early 2020.

Leader Kim Jong Un's wife, Ri Sol Ju, not seen in public for more than a year, is keeping a low profile to avoid infection risks, Ha said, citing the South's intelligence.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.